Status | Study |
Recruiting |
Study Name: Pathophysiology of Paget's Disease of Bone Condition: Paget's Disease of Bone Date: 2016-06-13 |
Active, not recruiting |
Study Name: Sodium Risedronate Tablets - Special Drug Use Surveillance in Patients With Osseous Paget's Disease (All-case Surveillance) -48-week Surveillance − Condition: Osseous Paget's Disease Date: 2014-04-03 Interventions: Drug: Sodium risedronate Sodium risedronate tablets |
Recruiting |
Study Name: Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD) Condition: Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia Date: 2011-01-26 |
Recruiting |
Study Name: Characterization of Familial Myopathy and Paget Disease of Bone Condition: Muscle Disorder Bone Disorder Date: 2010-07-20 Interventions: Device: Diffuse Optical Spectroscopy Diffuse Optical Spectroscopy |
Completed |
Study Name: Efficacy and Safety of Single Dose of 5 mg Zoledronic Acid in Chinese Patients With Paget's Disease of Bone (PDB) Condition: Paget's Disease of Bone Date: 2008-10-15 Interventions: Drug: Zoledronic acid 5mg, i.v. single dose |
Completed |
Study Name: Genetic Study of Families Affected by Paget's Disease of Bone Condition: Paget's Disease of Bone Date: 2008-09-05 |
Completed |
Study Name: Re-treatment of Patients With Paget's Disease Using Zoledronic Acid Condition: Paget's Disease of the Bone Date: 2008-08-21 Interventions: Drug: Zoledronic Acid Zoledronic acid 5 mg intravenous infusion once |
Completed |
Study Name: Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast® Condition: Paget's Disease of the Bone Hypocalcemia Date: 2008-04-22 Interventions: Drug: Reclast (ZOL446, zoledronic acid) |
Terminated |
Study Name: Inheritance of Osteosarcoma & Paget's Disease Through Chromosome 18: Condition: Osteosarcoma Paget's Disease Date: 2008-02-01 |
Completed |
Study Name: A Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETED) Condition: Paget's Disease of Bone Date: 2007-05-30 Interventions: Drug: alendronate Duration of Treatment : 6 Months O |